Dr Eilia Jafar a global leader in disaster management, environment, and humanitarian professional with over two decades of ...
It's the question that Professor Mohan Jacob and Dr. Adeel Zafar from Australia's James Cook University (JCU) sought to answer in their recent research, as detailed by Interesting Engineering.
Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.